Cargando…

Pricing Zolgensma – the world’s most expensive drug

Detalles Bibliográficos
Autor principal: Nuijten, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725676/
https://www.ncbi.nlm.nih.gov/pubmed/34992762
http://dx.doi.org/10.1080/20016689.2021.2022353
_version_ 1784626164643397632
author Nuijten, Mark
author_facet Nuijten, Mark
author_sort Nuijten, Mark
collection PubMed
description
format Online
Article
Text
id pubmed-8725676
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Routledge
record_format MEDLINE/PubMed
spelling pubmed-87256762022-01-05 Pricing Zolgensma – the world’s most expensive drug Nuijten, Mark J Mark Access Health Policy Short Communication Routledge 2021-12-29 /pmc/articles/PMC8725676/ /pubmed/34992762 http://dx.doi.org/10.1080/20016689.2021.2022353 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Nuijten, Mark
Pricing Zolgensma – the world’s most expensive drug
title Pricing Zolgensma – the world’s most expensive drug
title_full Pricing Zolgensma – the world’s most expensive drug
title_fullStr Pricing Zolgensma – the world’s most expensive drug
title_full_unstemmed Pricing Zolgensma – the world’s most expensive drug
title_short Pricing Zolgensma – the world’s most expensive drug
title_sort pricing zolgensma – the world’s most expensive drug
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725676/
https://www.ncbi.nlm.nih.gov/pubmed/34992762
http://dx.doi.org/10.1080/20016689.2021.2022353
work_keys_str_mv AT nuijtenmark pricingzolgensmatheworldsmostexpensivedrug